Literature DB >> 12207091

Inflammation, malnutrition and atherosclerosis in end-stage renal disease: a global perspective.

Marcelo M Nascimento1, Roberto Pecoits-Filho, Bengt Lindholm, Miguel C Riella, Peter Stenvinkel.   

Abstract

End-stage renal disease (ESRD) is characterized by an exceptional cardiovascular mortality rate. Although traditional risk factors are common in ESRD patients, they alone may not be sufficient to account for the high prevalence of cardiovascular disease (CVD). Recent evidence demonstrated that chronic inflammation, a non-traditional risk factor which is commonly observed in ESRD patients, may cause malnutrition and progressive atherosclerotic CVD by several pathogenetic mechanisms. Although both malnutrition and inflammation have been shown to be strong predictors of cardiovascular mortality in ESRD patients, it must be remembered that the majority of studies describing the presence of inflammation and malnutrition have been performed in Western and Asian industrialized countries. As it is evident that the prevalence of malnutrition and inflammation may differ markedly between different regions of the world and developing countries face a much higher prevalence of chronic infectious diseases, comparative inter-regional studies focusing on the etiology and prevalence of the malnutrition, inflammation and atherosclerosis syndrome are warranted. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12207091     DOI: 10.1159/000063559

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  9 in total

1.  The crossroad of RAAS modulation, inflammation, and oxidative stress in dialysis patients: light at the end of the tunnel?

Authors:  Joshua J Zaritsky; Kamyar Kalantar-Zadeh
Journal:  J Am Soc Nephrol       Date:  2012-01-12       Impact factor: 10.121

Review 2.  Statins, inflammation and kidney disease.

Authors:  Vera Krane; Christoph Wanner
Journal:  Nat Rev Nephrol       Date:  2011-05-31       Impact factor: 28.314

Review 3.  Inflammation and cachexia in chronic kidney disease.

Authors:  Wai W Cheung; Kyung Hoon Paik; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2010-01-29       Impact factor: 3.714

4.  Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases.

Authors:  Heloisa Reniers Vianna; Cristina Maria Bouissou M Soares; Katia Daniela Silveira; Gustavo Siqueira Elmiro; Philipe Melgaço Mendes; Marcelo de Sousa Tavares; Mauro Martins Teixeira; Débora Marques Miranda; Ana Cristina Simões E Silva
Journal:  Pediatr Nephrol       Date:  2012-11-18       Impact factor: 3.714

5.  Impact of living environment on 2-year mortality in elderly maintenance hemodialysis patients.

Authors:  Wen-Hung Huang; Ja-Liang Lin; Dan-Tzu Lin-Tan; Kuan-Hsing Chen; Ching-Wei Hsu; Tzung-Hai Yen
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

6.  In vitro and in vivo hypolipidemic properties of the aqueous extract of Spirulina platensis, cultivated in colored flasks under artificial illumination.

Authors:  Mahmoud A Al-Saman; Nada M Doleib; Mohamed R Ibrahim; Mohamed Y Nasr; Ahmed A Tayel; Ragaa A Hamouda
Journal:  PeerJ       Date:  2020-12-01       Impact factor: 2.984

7.  Cytomegalovirus infection causes an increase of arterial blood pressure.

Authors:  Jilin Cheng; Qingen Ke; Zhuang Jin; Haibin Wang; Olivier Kocher; James P Morgan; Jielin Zhang; Clyde S Crumpacker
Journal:  PLoS Pathog       Date:  2009-05-15       Impact factor: 6.823

8.  Tinzaparin provides lower lipid profiles in maintenance hemodialysis patients: a cross-sectional observational study.

Authors:  Ming-Hsien Tsai; Yu-Wei Fang; Jyh-Gang Leu
Journal:  ScientificWorldJournal       Date:  2014-11-13

9.  Allostimulatory capacity of conditionally immortalized proximal tubule cell lines for bioartificial kidney application.

Authors:  Milos Mihajlovic; Lambertus P van den Heuvel; Joost G Hoenderop; Jitske Jansen; Martijn J Wilmer; Annemarie J F Westheim; Wil A Allebes; Dimitrios Stamatialis; Luuk B Hilbrands; Rosalinde Masereeuw
Journal:  Sci Rep       Date:  2017-08-02       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.